GGrantIndex
Sort

40,608 grants matching prostate cancer

Molecular mechanisms of prostate cancer initiation

$1,247,302
Michael M. Shen · Columbia University Health Sciences · P01 · FY2013 · CA

Molecular-Based Therapy for Oral Cancer Prevention

$1,247,244
Scott M Lippman · University Of Tx Md Anderson Can Ctr · P01 · FY2009 · CA

Function Of Skeletal Matrix Genes

$1,246,298
Marian F Young · National Institute Of Dental & Craniofacial Research · ZIA · FY2011 · DE

Natural Products Discovery and Characterization Through Network Collaborations

$1,244,726
Lin Du · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

NYU BIOMARKER CLINICAL AND EPIDEMIOLOGIC CENTER

$1,244,611
New York University School Of Medicine · U01 · FY2001 · CA

Culturally Adapted Cognitive Behavioral Stress and Self-Management (CCBSM)

$1,244,397
Frank J Penedo · University Of Miami Coral Gables · R01 · FY2018 · CA

EXERCISE TO ENHANCE CARDIOVASCULAR HEALTH AMONG BLACK PROSTATE CANCER PATIENTS WITH ANDROGEN DEPRIVATION THERAPY: THE POWER TRIAL

$1,242,360
Dana-Farber Cancer Institute, Inc. · · FY2022 · Defense Health Agency

PRIMARY PRODUCT/SERVICE CODE TO: B537, DESCRIPTION: CENTRAL DATA COLLECTION CENTER (CDCC), WESTAT

$1,242,264
Sunitha Mathew · Westat, Inc. · N02 · FY2019 · CA

2/2 Cancer Research and Education to Advance HealTh Equity (CREATE) Partnership

$1,241,389
Maria Elena Martinez · University Of California, San Diego · U54 · FY2024 · CA

PROSTATE CANCER CLINICAL TRIALS GROUP

$1,240,167
Regents Of The University Of Michigan · · FY2009 · Department of Defense

VCU Massey Comprehensive Cancer Center NCI Community Oncology Research Program

$1,239,982
Khalid Matin · Virginia Commonwealth University · UG1 · FY2025 · CA

Novel Molecular Therapies of Prostate Cancer

$1,239,835
Dario C. Altieri · Wistar Institute · P01 · FY2017 · CA

Novel focused ultrasound enhanced calreticulin-nanoparticle for immune primed melanoma immunotherapy

$1,239,509
Ashish Ranjan · Ut Southwestern Medical Center · R37 · FY2025 · CA

Translational Applications of mda-7/IL-24 in Cancer

$1,239,416
Paul B Fisher · Columbia University Health Sciences · P01 · FY2006 · CA

MATCHES: Making Telehealth Delivery of Cancer Care at Home Effective and Safe

$1,238,986
Katherine S Panageas · Sloan-Kettering Inst Can Research · P50 · FY2025 · CA

MATCHES: Making Telehealth Delivery of Cancer Care at Home Effective and Safe

$1,238,984
Katherine S Panageas · Sloan-Kettering Inst Can Research · P50 · FY2022 · CA

Molecular and Functional Characterization of Colon Tumor Cancer Stem Cells and St

$1,238,550
Michael Clarke · Stanford University · U54 · FY2007 · CA

SYNTHETIC IMMUNE RECEPTOR TARGETING PSCA FOR THE TREATMENT OF PROSTATE CANCER

$1,237,500
University Of Southern California · · FY2022 · Defense Health Agency

3/3 Morehouse School of Medicine/Tuskegee University/University of Alabama at Birmingham O'Neal Comprehensive Cancer Center Partnership

$1,237,451
Upender Manne · University Of Alabama At Birmingham · U54 · FY2021 · CA

GENETIC EPIDEMIOLOGY OF LUNG CANCER

$1,236,518
University Of Cincinnati · U01 · FY2003 · CA

LEVERAGING DATA SCIENCE METHODS TO DELIVER INDIVIDUALIZED TREATMENT EFFECTS IN METASTATIC HORMONE SENSITIVE PROSTATE CANCER

$1,235,845
University Of Illinois · · FY2025 · Defense Health Agency

PROSTATE, LUNG, COLORECTAL AND OVARIAN (PLCO) CANCER SCREENING TRIAL - SCREEN

$1,235,772
Joel L Weissfeld · · N01 · FY2007 · CA

Translational Applications of mda-7/IL-24 in Cancer

$1,235,688
Paul B Fisher · Columbia University Health Sciences · P01 · FY2007 · CA

PCPT and SELECT Cohorts: Core Infrastructure Support for Cancer Research

$1,235,390
Catherine M. Tangen · Fred Hutchinson Cancer Research Center · U01 · FY2019 · CA

Modeling Precision Interventions for Prostate Cancer Control

$1,235,150
Ruth D Etzioni · Fred Hutchinson Cancer Center · U01 · FY2023 · CA